The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Astellas And Affinivax Team Up For Vaccine Against Pneumococcal Disease
The collaboration centers on Affinivax's multiple antigen presenting system to develop a vaccine targeted against pneumococcal disease.
Scientists Develop Primate Model Of Zika Virus
The primate model for the Asian-lineage Zika virus could help researchers evaluate potential vaccines and therapies, especially those that are intended for use during pregnancy.
Astellas, UTokyo To Collaborate On Cholera Vaccine
The partnership will develop a rice-based oral vaccine against cholera and E. coli-related diarrheal diseases.
Vaccine Helps Immune System ‘Remember’ Cancer Threats
When activated, a special type of modified cell called aAVC promotes the maturation of dendritic cells, the gatekeepers of immune memory.
Takeda To Develop Zika Vaccine With $19.8m BARDA Funding
The US$19.8 million initial funding will cover the development of a Zika vaccine through to a Phase I clinical trial.
Great Hesitation In Adopting Dengue Vaccine
Dengxavia, the world's first approved dengue vaccine, has been rolled out in parts of Asia and South America—but doubts over its efficacy and potential for causing side effects remain.
7 Must-Read Stories In October 2016
Sanofi Pasteur's dengue vaccine, low-protein diets and a ‘light-stopping’ experiment were popular in October.
Yellow Fever Vaccine Effective Even At Lower Dose
Lowering the dose of the yellow fever vaccine could help extend population coverage even if reduces the vaccine's efficacy, study says.
What You Need To Know About Takeda’s Dengue Vaccine
Derek Wallace, global dengue program medical director of Takeda Pharmaceutical Company, on the company's plans for dengue and Zika vaccines.